Kala Bio, Inc. (KALA)
0.57
+0.03
(+5.97%)
USD |
NASDAQ |
Sep 09, 13:40
Kala Bio Price to Book Value : 1.219 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.150 |
| September 04, 2026 | 1.085 |
| September 03, 2026 | 1.200 |
| September 02, 2026 | 1.117 |
| September 01, 2026 | 1.138 |
| August 31, 2026 | 1.438 |
| August 28, 2026 | 1.476 |
| August 27, 2026 | 1.737 |
| August 26, 2026 | 1.745 |
| August 25, 2026 | 1.756 |
| August 24, 2026 | 1.701 |
| August 21, 2026 | 1.754 |
| August 20, 2026 | 1.796 |
| August 19, 2026 | 1.924 |
| August 18, 2026 | 1.922 |
| August 17, 2026 | 1.946 |
| August 14, 2026 | 2.022 |
| August 13, 2026 | 1.976 |
| August 12, 2026 | 1.890 |
| August 11, 2026 | 1.807 |
| August 10, 2026 | 1.614 |
| August 07, 2026 | 1.599 |
| August 06, 2026 | 1.576 |
| August 05, 2026 | 1.499 |
| August 04, 2026 | 1.589 |
| Date | Value |
|---|---|
| August 03, 2026 | 1.674 |
| July 31, 2026 | 1.616 |
| July 30, 2026 | 1.560 |
| July 29, 2026 | 1.44 |
| July 28, 2026 | 1.412 |
| July 27, 2026 | 1.434 |
| July 24, 2026 | 1.356 |
| July 23, 2026 | 1.305 |
| July 22, 2026 | 1.575 |
| July 21, 2026 | 1.568 |
| July 20, 2026 | 1.604 |
| July 17, 2026 | 1.659 |
| July 16, 2026 | 1.811 |
| July 15, 2026 | 2.202 |
| July 14, 2026 | 2.060 |
| July 13, 2026 | 2.331 |
| July 10, 2026 | 2.513 |
| July 09, 2026 | 2.887 |
| July 08, 2026 | 2.972 |
| July 07, 2026 | 3.229 |
| July 06, 2026 | 3.293 |
| July 02, 2026 | 3.592 |
| July 01, 2026 | 3.806 |
| June 30, 2026 | 3.699 |
| June 29, 2026 | 3.611 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.664 |
| Alnylam Pharmaceuticals, Inc. | 25.21 |
| Anika Therapeutics, Inc. | 2.036 |
| Savara, Inc. | 7.714 |
| Vericel Corp. | 5.368 |
Price to Book Value Related Metrics
| Price | 0.57 |
| Earnings Yield | -12.97K% |
| Market Cap | 11.02M |